alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EHTH.6.30.14.EXHIBIT10.2






Supplemental Agreement


Lessor༚o Xiamen Software Industry Investment & Development Co., Ltd (Hereinafter Party A)
	
						
	Legal Address:  
	1F Area A, Huaxun Building, Xiamen Software Park, Torch Hi-tech Zone

	Zip Code: 
	361005
	Tel:
	3929999
	Fax:
	3929888

	Legal Representative:
	 
	Title:
	Chairman of the Board
	 
	 

	Bank Account:
	Torch Sub-branch of China Merchants Bank
	Account No:
	[Account Number]
	 
	 






Renter༚oeHealth China (Xiamen) Technology Co., Ltd (Hereinafter Party B)
	
							
	Legal Address:  
	9F Area A, Huaxun Building, Xiamen Software Park, Torch Hi-tech Zone
	 

	Zip Code: 
	361000
	Tel:
	2517000
	Fax:    02513555
	 

	Legal Representative:
	 
	Title:
	 
	 
	 

	Bank Account:
	 
	Account No:
	 
	 
	 






After friendly negotiation, Party A and Party B have reached an agreement regarding Party B’s renting of office spaces on 8F, Area B (Area: 1250.89 square meters) in Chuangxin Building at Software Park located at Xiamen Torch Hi-tech zone as follows:


Item I.         Amendments


		
	1.
	This agreement is an amendment to the Office Lease Contract executed on September 23, 2009 (and all appendices that both parties have been involved, including all renewal agreements and the Agreement of Assignment and Transfer) (collectively referred hereinafter as the “Original Contract”) and shall supplement the Original Contract.




		
	2.
	Effective September 15, 2013, Item 4 of the Original Contract shall be changed so that the rental price for the space provided by Party A shall be adjusted to RMB 47/m2O per month.  Item 5 of the Original Contract shall be changed so that the total rent will be RMB 58,792 per month.  Item 6 of the Original Contract regarding the amount of deposit shall be changed to RMB 176,376.  All other Items in the Original Contract shall remain unchanged.




		
	3.
	If Party A decides not to continue the lease with Party B, it needs to provide written notice to Party B 120 days in advance so that Party B will have sufficient time to search for appropriate office space. If Party B decides not to continue the lease with Party A, it also needs to provide 120 advance written notice to Party A.




		
	4.
	Any conflicts between this agreement and the Original Contract, this agreement shall prevail.




Item II.     Effective Date


This agreement shall be effective on the date the authorized representatives of both Party A and Party B have signed this agreement and applied the company’s stamp. 




Item III.     Copies











There are two copies of this agreement, each party holds one copy, and each copy bears equal legal validity. 


(Below contains no formal contractual provisions.)


Party A: Xiamen Software Industry Investment and Development Co., Ltd
Authorized Representative:  /s/ WANG Hua
Date:    September 9, 2013


Party B:  eHealth China (Xiamen) Technology Co., Ltd 
Authorized Representative:     /s/ Jiang WU
Date:     September 9, 2013
Order filed November 17 , 2020

In The 

## Fourteenth Court of Appeals

____________ NO. 14

- 20

- 0075 6

- CV

____________ NASSER CHEHAB , Appellant

V. WILLIAM PAT HUTTENBACH HIRSCH AND WESTHEIMER, P.C. , Appellee s

On Appeal from the 189th District Court

Harr i s County, Texas Trial Court Cause No. 2020

- 46707



### ORDER

T h i s i s a n a t t e m p t e d a p p e a l f r o m a n order on app ellant ’ s motion to show authority signed by the trial court on October 7, 2020, and an order on appellee s ’ motion to dismiss pursuant to Rule 91a or , al ternatively, motion for summary judgment, signed by the trial court on October 15, 2020. See Tex. R. Civ. P. 91a. Pursuant to chapter 11 of the Texas Civil Practice and Remedies Code, Nasser2

Chehab has been declared a vexatious litigant and is therefore su bject to the pre

fili ng order under section 11.101. Tex. Civ. Prac. & Rem. Code §§ 11.101, 11.103

. Under section 11.103(a), the clerk of this court may not file an appeal presented by a vexatious litigant subject to a pre

- filing order under section 11.10 1 unless the litigant obtains an order from the local administrative judge permitting the filing, or the appeal is from a pre

- filing order entered under section 11.101 designating a perso n a vexatious litigant. Tex. Civ. Prac. & Rem. Code § 11.103(a) & (d)

. T his is not an appeal from a pre

- filing order entered under section 11.101.
This court will consider dismissal of this appeal unless appellant, within 10 days of the date of this order, files a copy of the order from the local administrative judge perm it t ing the filing of this appeal. See Tex. Civ. Prac. & Rem. Code § 11.103(a).

PER CURIAM

Panel Consists of Chief Justice Frost and Justices Jewell and Poissant.
EXHIBIT
32.2




WRITTEN
STATEMENT


PURSUANT
TO


18
U.S.C. SECTION 1350




In
connection with the Quarterly Report of Lihua International, Inc. and its
subsidiaries (the “Company”) on Form 10-Q/A for the period ended March 31, 2010
as filed with the Securities and Exchange Commission on the date hereof (the
“Report”), the undersigned, Yang “Roy” Yu  Chief Financial Officer of the
Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1) The
Report fully complies with the requirements of Section 13a-14(b) or
15d-14(b) of the Securities Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





Dated:
      July 12, 2010
              By:
              /s/ Yang “Roy” YuName:
              Yang
      “Roy” YuTitle:
              Chief
      Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

                    Notice is hereby given that, on July 15, 2024, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1933, 15 U.S.C. 4301*et seq.*                     (“the Act”), Petroleum Environmental Research Forum (“PERF”) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, CDM Smith Inc., Houston, TX, has been added as a party to this venture.                

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PERF intends to file additional written notifications disclosing all changes in membership.

                    On February 10, 1986, PERF filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to section 6(b) of the Act on March 14, 1986 (51 FR 8903).                

                    The last notification was filed with the Department on June 2, 2023. A notice was published in the                     **Federal Register**                     pursuant to section 6(b) of the Act on August 22, 2023 (88 FR 57129).                

Suzanne Morris,

Deputy Director Civil Enforcement Operations, Antitrust Division.

[FR Doc. 2024-23598 Filed 10-10-24; 8:45 am]

BILLING CODE 4410-11-P
EXHIBIT
32.2





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Atlas Resources Public 17-2008 (B) L.P.
(the "Partnership") on Form 10-Q for the period ended September 30, 2009 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Matthew A. Jones, Chief Financial Officer of the Partnership,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:





(1)
            the
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934,
and


(2)
            the
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Partnership.





By:
            /s/ Matthew A.
      JonesName:
            Matthew
      A. JonesTitle:
            Chief
      Financial Officer of the Managing General PartnerDate:
            November
      16, 2009
EXHIBIT 32.1





CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of Adrenalina (the "Company") on Form 10-Q/A-1 for the period ended September 30,  2011  as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:





1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.





3.  A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.





Date:  October 5, 2011By:
/s/ Ilia LekachIlia LekachChief Executive Officer
-   

# Strategic Partnerships

ORNL conducts research with individuals and organizations outside the Lab to accelerate the speed with which ORNL-developed technology goes to market, impacting US competitiveness. We tailor these partnerships and the resulting contractual agreements to fit our partners—other national laboratories, a range of federal entities, industry, or nonprofit organizations—and type of available funding. Partnering with ORNL also provides access to Department of Energy user facilities and avenues for partnering specifically with small businesses.

## Types of agreements

Work done for businesses and other nonfederal entities using specialized or unique facilities or expertise.

ORNL and a partner outside the federal government collaborate and share the results of a research and development project.

Users may access facilities, specialized equipment, instrumentation, and personnel to conduct research.

USER FACILITIES
# L_2011255EN.01001301.xml

| 1.10.2011 | EN | Official Journal of the European Union | L 255/13 |
| --- | --- | --- | --- |

1.10.2011

EN

Official Journal of the European Union

L 255/13

---

COUNCIL RECOMMENDATION

of 15 February 2011

concerning the discharge to be given to the Commission in respect of the implementation of the operations of the European Development Fund (eighth EDF) for the financial year 2009

(2011/645/EU)

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to the fourth ACP-EEC Convention, signed at Lomé on 15 December 1989 (1) and amended by the Agreement signed in Mauritius on 4 November 1995 (2),

Having regard to the Internal Agreement between the representatives of the Governments of the Member States, meeting within the Council, on the financing and administration of the Community aid under the Second Financial Protocol to the fourth ACP-EC Convention (3) (the ‘Internal Agreement’) setting up, amongst others, the eighth European Development Fund (eighth EDF), and in particular Article 33(3) thereof,

Having regard to the Financial Regulation of 16 June 1998 applicable to development finance cooperation under the fourth ACP-EC Convention (4), and in particular Articles 66 to 74 thereof,

Having examined the revenue and expenditure account and the balance sheet relating to the operations of the eighth EDF as at 31 December 2009, and the Annual Report of the Court of Auditors on the activities funded by the eighth, ninth and tenth European Development Funds (EDFs) (5), concerning the financial year 2009, together with the Commission’s replies contained in that Annual Report,

Whereas:

| (1) | Pursuant to Article 33(3) of the Internal Agreement, the discharge for the financial management of the eighth EDF is to be given to the Commission by the European Parliament on the recommendation of the Council. |
| --- | --- |

(1)

Pursuant to Article 33(3) of the Internal Agreement, the discharge for the financial management of the eighth EDF is to be given to the Commission by the European Parliament on the recommendation of the Council.

| (2) | The overall implementation by the Commission of the operations of the eighth EDF during the financial year 2009 has been satisfactory, |
| --- | --- |

(2)

The overall implementation by the Commission of the operations of the eighth EDF during the financial year 2009 has been satisfactory,

HEREBY RECOMMENDS that the European Parliament give the Commission a discharge in respect of the implementation of the operations of the eighth EDF for the financial year 2009.

Done at Brussels, 15 February 2011.

For the Council

The President

MATOLCSY Gy.

---

(1)  
  OJ L 229, 17.8.1991, p. 3.

1

(2)  
  OJ L 156, 29.5.1998, p. 3.

2

(3)  
  OJ L 156, 29.5.1998, p. 108.

3

(4)  
  OJ L 191, 7.7.1998, p. 53.

4

(5)  
  OJ C 303, 9.11.2010, p. 243.

5

---
Attachment 1 A 

FY 2019 VERAs, VSIPs PROCESSING COSTS UNDER THE 

FURTHER ADDITIONAL CONTINUING APPROPRIATIONS ACT, 2019 P.L. 116-5 

REMITTANCE REPORT FOR FY 2019 VERAs 

Remittance Date: 

Reporting Entity: POC Name: 

FY 2019 Retirement Month: 

(MM/YYYY) 

POC Email address: POC Phone Number: 

Funds submitted by: 

(Indicate IPAC, EFT or CHECK) 

IPAC 

EFT FY 2019 VERAs 

CHECK 

Payroll Office Number: 

(Column 1) 

Agency Location Code: 

(Column 2) 

Number of Covered Employees 

(Column 3) 

Amount Submitted 

Column 3 x $390.00 

FERS

TOTALS (A) $ 

CSRS

TOTALS (B) $ 

AMOUNT SUBMITTED $ 

(Must Equal A + B) 

I certify to the best of my knowledge, the accuracy and completeness of this Remittance Report. (To Be Reproduced Locally) 

(Use additional forms if needed) 

Signature Name - Printed 
 

 

 

 

 

 

Attachment 1 B 

FY 2019 VERAs, VSIPs PROCESSING COSTS UNDER THE 

FURTHER ADDITIONAL CONTINUING APPROPRIATIONS ACT, 2019 P.L. 116-5 

REMITTANCE REPORT FOR FY 2019 VSIP 

Remittance Date: 

Reporting Entity: POC Name: 

FY 2019 Retirement Month: 

(MM/YYYY) 

POC Email address: POC Phone Number: 

Funds submitted by: 

(Indicate IPAC, EFT or CHECK) 

IPAC 

EFT FY 2019 VSIPs 

CHECK 

Payroll Office Number: 

(Column 1) 

Agency Location Code: 

(Column 2) 

Number of Covered Employees 

(Column 3) 

Amount Submitted 

Column 3 x $390.00 

FERS

TOTALS (A) $ 

CSRS

TOTALS (B) $ 

AMOUNT SUBMITTED $ 

(Must Equal A + B) 

I certify to the best of my knowledge, the accuracy and completeness of this Remittance Report. (To Be Reproduced Locally) 

(Use additional forms if needed) 

Signature Name - Printed 
 

 

 

 

 

 

 

Attachment 1 C 

FY 2019 VERAs, VSIPs PROCESSING COSTS UNDER THE 

FURTHER ADDITIONAL CONTINUING APPROPRIATIONS ACT, 2019 P.L. 116-5 

REMITTANCE REPORT FOR FY 2019 VERAs with VSIPs 

Remittance Date: 

Reporting Entity: POC Name: 

FY 2019 Retirement Month: 

(MM/YYYY) 

POC Email address: POC Phone Number: 

Funds submitted by: 

(Indicate IPAC, EFT or CHECK) 

IPAC 

EFT FY 2019 VERAs with VSIPs 

CHECK 

Payroll Office Number: 

(Column 1) 

Agency Location Code: 

(Column 2) 

Number of Covered Employees 

(Column 3) 

Amount Submitted 

Column 3 x $390.00 

FERS

TOTALS (A) $ 

CSRS

TOTALS (B) $ 

AMOUNT SUBMITTED $ 

(Must Equal A + B) 

I certify to the best of my knowledge, the accuracy and completeness of this Remittance Report. (To Be Reproduced Locally) 

(Use additional forms if needed) 

Signature Name - Printed
##### 



Exhibit 32.2
 Certification Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
    Dated: May 3, 2007
    /s/ Chris D. NorthChris D. NorthChief Financial Officer
**Final Listing of Questionnaire Files for Steam Electric Rulemaking Record**

**Plant ID 04150**  **Removed from Public**  **(Non-CBI) Docket**  **1 Copyright** 

**Flag 2**  **File Name Description**  x 04150\04150_Checklist.xls EPA Technical Review Checklist Workbook

04150\04150_Completeness_Checklist.xls EPA Completeness Review Checklist 04150\04150_HardcopyLog.doc EPA log of hardcopy documents submitted x 04150\04150_PartA.xls Plant submitted survey file x 04150\04150_PartE.xls Plant submitted survey file x 04150\04150_PartH.xls Plant submitted survey file

04150\Certification Statement Plant ID 04150.pdf Plant certification statement x 04150\Supplemental Documents\04150_Lake Hubbard Property Map.pdf Plant submitted supplemental files to the survey x 04150\Supplemental Documents\04150_LHSES Water Balance Diagram.pdf Plant submitted supplemental files to the survey

1Final reviewed survey responses are located in the Steam Electric Technical Questionnaire Database
. 2Copyright documents are available from the docket.
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  1.
    
    I have reviewed this quarterly report on Form 10-Q of National American University Holdings,
Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the period presented in this
report;4.
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
     5.
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or person performing the equivalent
functions):




---



##### 



/s/ Ronald ShapeRonald L. Shape, Ed. D.Chief Executive Officer
Exhibit 10.13

 

CONFIDENTIAL TREATMENT REQUESTED

 

AMENDMENT AGREEMENT NO. 3 TO THE RESEARCH COLLABORATION
 AND LICENSE AGREEMENT

 

This Amendment Agreement No. 3 (“Amendment 3”) is made to the BACE Research Collaboration and License Agreement between Vitae Pharmaceuticals, Inc. (“Vitae”), with offices at 502 West Office Center Drive, Fort Washington, PA 19034, USA (taxpayer ID number 04-03567753), and Boehringer Ingelheim International GmbH (“BI”), with offices at ****(VAT ID number ****), effective as of June 4, 2009, as last amended by the Amendment No. 2 (“Amendment 2”) dated December 21, 2012 (together the “Agreement”).

 

WHEREAS, according to Article 3 of the Amendment 2 Vitae and BI have agreed to extend the Core Indication and according to Section 4.b to a Development milestone for Candidate Feasibility.

 

WHEREAS, BI is developing ****and has decided to move the Development Candidate into Phase I studies.

 

Therefore, the Parties agree to the following:

 

1.              If not defined in this Amendment all words capitalized in this Amendment shall have the same meaning as defined in the Agreement.

 

2.              The full milestone payment for Initiation of Phase I studies according to Section 9.3.1 for ****shall be due upon execution of this Amendment 3 and receipt of an invoice fulfilling the criteria according to the Agreement.

 

3.              Article 4 of Amendment 2 shall be replaced as follows:

 

“For the first achievement of the Development milestone of ****in a Core Indication according to Section 3.b. of this Amendment, BI shall pay Vitae ****.  For achievement of all other Development and regulatory milestones, the milestone payments as provided in Section 9.3 of the Agreement remain unchanged.”

 

4.              Save as amended, all other terms and conditions of the Agreement shall remain unchanged.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK.
 SIGNATURES FOLLOW.]

 

****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION.  CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

 

1











 

IN WITNESS WHEREOF, Vitae and BI, by their duly authorized officers, have executed this Amendment as of the last date signed below.

 

	
VITAE PHARMACEUTICALS, INC.
    	
BOEHRINGER   INGELHEIM
    
	
 
    	
INTERNATIONAL   GMBH
    
	
 
    	
 
    
	
 
    	
 
    
	
Date: ****
    	
Date:   ****
    
	
 
    	
 
    
	
By: ****
    	
By:   ****
    
	
 
    	
 
    
	
Name: ****
    	
Name:   ****
    
	
 
    	
 
    
	
Title: ****
    	
Title:   ****
    


 

****CERTAIN INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION.  CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.

 

2